Swiss All Share Index
17.196,03
PKT
+87,75
PKT
+0,51
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.04.14 | Holcim buy | UBS AG | |
| 07.04.14 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 07.04.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 07.04.14 | Holcim Neutral | JP Morgan Chase & Co. | |
| 07.04.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 07.04.14 | Holcim Hold | Deutsche Bank AG | |
| 07.04.14 | Holcim buy | Deutsche Bank AG | |
| 07.04.14 | Holcim Outperform | BNP PARIBAS | |
| 07.04.14 | Holcim Outperform | BNP PARIBAS | |
| 07.04.14 | Holcim buy | Kelper Cheuvreux | |
| 07.04.14 | Holcim buy | Kelper Cheuvreux | |
| 07.04.14 | Holcim Neutral | Credit Suisse Group | |
| 07.04.14 | Holcim Outperform | Credit Suisse Group | |
| 07.04.14 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
| 04.04.14 | Swiss Re Equal weight | Barclays Capital | |
| 04.04.14 | Zurich Insurance kaufen | JP Morgan Chase & Co. | |
| 03.04.14 | Nestlé buy | Citigroup Corp. | |
| 02.04.14 | Nestlé Outperform | Bernstein Research | |
| 02.04.14 | Roche buy | Deutsche Bank AG | |
| 02.04.14 | Novartis Hold | Deutsche Bank AG | |
| 01.04.14 | Givaudan overweight | JP Morgan Chase & Co. | |
| 01.04.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 01.04.14 | Roche overweight | JP Morgan Chase & Co. | |
| 01.04.14 | Novartis buy | UBS AG | |
| 31.03.14 | UBS overweight | JP Morgan Chase & Co. | |
| 28.03.14 | Novartis buy | UBS AG | |
| 28.03.14 | Nestlé Neutral | Credit Suisse Group | |
| 27.03.14 | Nestlé Neutral | UBS AG | |
| 26.03.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 26.03.14 | Novartis buy | UBS AG | |
| 26.03.14 | Nestlé Hold | Deutsche Bank AG | |
| 25.03.14 | UBS buy | UBS AG | |
| 24.03.14 | Swiss Re Underperform | Bernstein Research | |
| 24.03.14 | Holcim Sell | Goldman Sachs Group Inc. | |
| 24.03.14 | Novartis buy | UBS AG | |
| 21.03.14 | Roche buy | Deutsche Bank AG | |
| 21.03.14 | Novartis buy | UBS AG | |
| 20.03.14 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 20.03.14 | UBS Neutral | Macquarie Research | |
| 20.03.14 | UBS Outperform | Macquarie Research |